Followers | 122 |
Posts | 17590 |
Boards Moderated | 0 |
Alias Born | 02/21/2012 |
Saturday, July 26, 2014 2:37:19 PM
With respect to the outstanding shares refer to this link , go to financials and disclosures, go the March 13, 2013 release on preferred e shares. https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=101220
As you can see additional shares will be issued to support the conversion requirements. It's black and white here.
The reason I have not converted is because the price of the commons are .0001 - the lowest price possible. With series e preferred being anti dilutive there is no reason to convert now. I can wait. However, the company should negotiate now with series e holders as they hold the key to future dilution of common shares. If the company wants to increase shareholder value they must address this very key issue with series e holders. Until they do I can't imagine anyone touching common shares with a 10 foot pole.
My opinion as always.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM